Skip to main content

Advertisement

Log in

Genetically determined neuropathy (CMT 1A) accompanied by immune dysfunction: a case report

  • Short Communication
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Peripheral Myelin Protein 22 (PMP22) is mostly expressed in Schwann cells where it is essential in the compaction of myelin. The duplication of the PMP22 gene results in a hereditary demyelinating neuropathy of the Charcot–Marie–Tooth type 1A (CMT1A). So far there are only a few case reports suggesting that dysimmune mechanisms may take part in the pathophysiology of this disease. We describe three siblings carrying the duplication of the PMP22 gene, with a significant reduction of serum immunoglobulin G levels in all three cases and sural nerve vasculitis in the two women, which supports the proposition, that immune dysfunction may accompany this disease in some cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wang IC, Kroner A, Fischer S, Berghoff M, Kobsar I, Maurer M, et al. Role of immune cells in animal models for inherited peripheral neuropathies. Neuromolecular Med. 2006;8:175–90.

    Article  Google Scholar 

  2. Aarskog NK, Vedeler CA. Real-time quantitative polymerase chain reaction. Hum Genet. 2000;107:494–8.

    Article  PubMed  CAS  Google Scholar 

  3. Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, et al. Coexistent hereditary and inflammatory neuropathy. Brain. 2004;127:193–202.

    Article  PubMed  Google Scholar 

  4. Gabriel C, Gregson NA, Wood NW, Hughes RA. Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry. 2002;72:230–5.

    Article  PubMed  CAS  Google Scholar 

  5. Williams L, Shannon BT, Wright FS. Circulating cytotoxic immune components in dominant Charcot–Marie–Tooth syndrome. J Clin Immunol. 1993;13:389–96.

    Article  PubMed  CAS  Google Scholar 

  6. Schmid C, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci. 2000;20:729–35.

    PubMed  CAS  Google Scholar 

  7. Ritz M, Lechner-Scott J, Scott RJ, Fuhr P, Malik N, Erne B, et al. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neuroimmunol. 2000;104:155–63.

    Article  PubMed  CAS  Google Scholar 

  8. Williams L, Penn GM. Selective IgA deficiency in Charcot–Marie–Tooth disease. Am J Clin Pathol. 1979;72:800–6.

    PubMed  CAS  Google Scholar 

  9. Rankin EC, Isenberg DA. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus. 1997;6:390–4.

    Article  PubMed  CAS  Google Scholar 

  10. Pareyson D, Dell’Anna E, DiMonda T, Scaioli V, Ciano C, Sghirlanzoni A, et al. Influence of gender and pregnancy on CMT1A. J Peripher Nerv Syst. 2004;9:118.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Györgyi Bathori and Marianna Marko for their excellent technical help.

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Judit Molnar.

Additional information

Responsible Editor: G. Geisslinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pál, Z., Kiss, E., Gál, A. et al. Genetically determined neuropathy (CMT 1A) accompanied by immune dysfunction: a case report. Inflamm. Res. 58, 359–361 (2009). https://doi.org/10.1007/s00011-009-0025-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-009-0025-7

Keywords

Navigation